Techs led another stock market sell-off. It's a time to be defensive. Apple, Palantir, jobs and midterm elections loom.
Why AMGN Stock advanced +1.97% Today — RQD Quant Desk Flash
Amgen Inc. (AMGN) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why AMGN Stock advanced +1.97% Today — RQD Quant Desk Flash
Amgen Inc. (AMGN) advanced +1.97% to $460.73 as options desks priced 60% call premium vs. 40% put protection around the $452 max-pain magnet. Solid 67% profit margin (15% return on capital), mixed timing at 32x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 92% of its 52-week range ($292.12 – $475.65) with RSI-14 at 71.4 (OVERBOUGHT (>70)).
- ▸Whale Options Positioning: $26.7M in bullish call flow vs. $18.1M in put flow (Put/Call 0.68x, implied earnings swing ±6.5%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 67.2% gross margin and $8.1B annual free cash flow.
Amgen can appeal to various kinds of investors.
Preview next weekâs market movers: jobs data, PMI reports, major earnings from Apple and AMD, and IPO buzz. Read here for more details.
Amgen (AMGN) has been in focus after positive Phase 3 data for IMDELLTRA in extensive stage small cell lung cancer and Tezspire in eosinophilic esophagitis, alongside analysts lifting near term earnings expectations. Rec
Mattel has appointed former Amgen Executive Vice President and CFO Peter Griffith as its new Chief Financial Officer and as a non-independent director, effective October 20, 2026, with outgoing CFO Paul Ruh supporting th
Private bankers have seen elevated demand for multimillion-dollar loans since last year, as stocks offer a much better return than tying up cash in a mansion.
Techs led another stock market sell-off. It's a time to be defensive. Apple, Palantir, jobs and midterm elections loom.
The S&P 500 Index ($SPX ) (SPY ) is down -1.26%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.52%. December E-mini S&P futures (ESZ26 ) are down -1.
Key TakeawaysRegeneron shares jumped 12% after third-quarter revenue rose 36% to $5. 1 billion.
The Nasdaq dives Friday as Amazon stock and Intel both plunge on disappointing earnings reports.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live AMGN Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
AMGN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +10.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AMGN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AMGN. Explore sector supply chains on /butterfly.
AMGN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AMGN stock moving today?
Why AMGN Stock advanced +1.97% Today — RQD Quant Desk Flash. Solid 67% profit margin (15% return on capital), mixed timing at 32x P/E—hold if owned, no rush to chase.